A missing label leaves questions open
The FDA, the US Food and Drug Administration, has not reviewed a KPV product label for patients, as of September 28, 2026.
There is too little information to show that KPV is safe to use with other medicines. One medicine can change another’s effect; that is called an interaction.
Ask what evidence supports the answer when someone says an option fits your situation.
Pregnancy information is absent
As of September 28, 2026, FDA’s KPV review found no records of people receiving KPV and no animal studies of its effects on having children or a baby’s growth before birth.
There is no FDA-reviewed KPV advice about pregnancy or breastfeeding.
Bring pregnancy, breastfeeding or plans for pregnancy into the health discussion if they are relevant to you.
Put your full situation on the table
Take a record of your medicines, supplements, allergies and past care. Include anything you have already used under the KPV name.
Ask your doctor or another licensed health professional to explain what is known, what is not known and which other treatments address the same problem.
A reassuring answer cannot replace the missing KPV treatment studies in people.